Literature DB >> 26400570

The Influence of CKD on Colonic Microbial Metabolism.

Ruben Poesen1, Karen Windey2, Ellen Neven3, Dirk Kuypers1, Vicky De Preter3, Patrick Augustijns4, Patrick D'Haese3, Pieter Evenepoel1, Kristin Verbeke2, Björn Meijers5.   

Abstract

There is increasing interest in the colonic microbiota as a relevant source of uremic retention solutes accumulating in CKD. Renal disease can also profoundly affect the colonic microenvironment and has been associated with a distinct colonic microbial composition. However, the influence of CKD on the colonic microbial metabolism is largely unknown. Therefore, we studied fecal metabolite profiles of hemodialysis patients and healthy controls using a gas chromatography-mass spectrometry method. We observed a clear discrimination between both groups, with 81 fecal volatile organic compounds detected at significantly different levels in hemodialysis patients and healthy controls. To further explore the differential impact of renal function loss per se versus the effect of dietary and other CKD-related factors, we also compared fecal metabolite profiles between patients on hemodialysis and household contacts on the same diet, which revealed a close resemblance. In contrast, significant differences were noted between the fecal samples of rats 6 weeks after 5/6th nephrectomy and those of sham-operated rats, still suggesting an independent influence of renal function loss. Thus, CKD associates with a distinct colonic microbial metabolism, although the effect of renal function loss per se in humans may be inferior to the effects of dietary and other CKD-related factors. The potential beneficial effect of therapeutics targeting colonic microbiota in patients with CKD remains to be examined.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; intestine; nutrition

Mesh:

Year:  2015        PMID: 26400570      PMCID: PMC4849823          DOI: 10.1681/ASN.2015030279

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

1.  Development of a screening method to determine the pattern of fermentation metabolites in faecal samples using on-line purge-and-trap gas chromatographic-mass spectrometric analysis.

Authors:  Vicky De Preter; Greet Van Staeyen; Diederik Esser; Paul Rutgeerts; Kristin Verbeke
Journal:  J Chromatogr A       Date:  2009-01-08       Impact factor: 4.759

2.  Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.

Authors:  Sophie Liabeuf; Daniela V Barreto; Fellype C Barreto; Natalie Meert; Griet Glorieux; Eva Schepers; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2009-11-13       Impact factor: 5.992

3.  Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.

Authors:  M Hida; Y Aiba; S Sawamura; N Suzuki; T Satoh; Y Koga
Journal:  Nephron       Date:  1996       Impact factor: 2.847

4.  Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis.

Authors:  Fumio Takayama; Kentaro Taki; Toshimitsu Niwa
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

5.  Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism.

Authors:  E A Smith; G T Macfarlane
Journal:  J Appl Bacteriol       Date:  1996-09

6.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

7.  Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

Authors:  Ruben Poesen; Liesbeth Viaene; Kristin Verbeke; Kathleen Claes; Bert Bammens; Ben Sprangers; Maarten Naesens; Yves Vanrenterghem; Dirk Kuypers; Pieter Evenepoel; Björn Meijers
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

8.  Free p-cresol is associated with cardiovascular disease in hemodialysis patients.

Authors:  B K I Meijers; B Bammens; B De Moor; K Verbeke; Y Vanrenterghem; P Evenepoel
Journal:  Kidney Int       Date:  2008-02-27       Impact factor: 10.612

9.  Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.

Authors:  Jakk Wong; Yvette M Piceno; Todd Z DeSantis; Madeleine Pahl; Gary L Andersen; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2014-03-08       Impact factor: 3.754

10.  Cohabiting family members share microbiota with one another and with their dogs.

Authors:  Se Jin Song; Christian Lauber; Elizabeth K Costello; Catherine A Lozupone; Gregory Humphrey; Donna Berg-Lyons; J Gregory Caporaso; Dan Knights; Jose C Clemente; Sara Nakielny; Jeffrey I Gordon; Noah Fierer; Rob Knight
Journal:  Elife       Date:  2013-04-16       Impact factor: 8.140

View more
  48 in total

Review 1.  Microbiota issue in CKD: how promising are gut-targeted approaches?

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Alice Sabatino; Enrico Fiaccadori; Biagio Raffaele Di Iorio; Loreto Gesualdo
Journal:  J Nephrol       Date:  2018-08-01       Impact factor: 3.902

Review 2.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

3.  Anthraquinone-containing compound in rhubarb prevents indole production via functional changes in gut microbiota.

Authors:  Kento Takayama; Shoji Maehara; Norihiko Tabuchi; Nobuyuki Okamura
Journal:  J Nat Med       Date:  2020-10-19       Impact factor: 2.343

Review 4.  Complementary Methodologies To Investigate Human Gut Microbiota in Host Health, Working towards Integrative Systems Biology.

Authors:  Manuel Ferrer; David Rojo; Celia Méndez-García; Coral Barbas
Journal:  J Bacteriol       Date:  2018-01-10       Impact factor: 3.490

Review 5.  The gut-kidney axis.

Authors:  Pieter Evenepoel; Ruben Poesen; Björn Meijers
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

6.  Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.

Authors:  Ruben Poesen; Kathleen Claes; Pieter Evenepoel; Henriette de Loor; Patrick Augustijns; Dirk Kuypers; Björn Meijers
Journal:  J Am Soc Nephrol       Date:  2016-05-26       Impact factor: 10.121

Review 7.  Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.

Authors:  Jing Gong; Sanjeev Noel; Jennifer L Pluznick; Abdel Rahim A Hamad; Hamid Rabb
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

Review 8.  Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review.

Authors:  Irene Sarosiek; Rudolf Schicho; Pedro Blandon; Mohammad Bashashati
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

Review 9.  Gut microbiome in chronic kidney disease: challenges and opportunities.

Authors:  Anitha Nallu; Shailendra Sharma; Ali Ramezani; Jagadeesan Muralidharan; Dominic Raj
Journal:  Transl Res       Date:  2016-04-30       Impact factor: 7.012

10.  From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.

Authors:  Milena B Stockler-Pinto; Christophe O Soulage; Natália A Borges; Ludmila F M F Cardozo; Carla J Dolenga; Lia S Nakao; Roberto Pecoits-Filho; Denis Fouque; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2017-11-18       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.